EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model.

Wang T, Gantier MP, Xiang D, Bean AG, Bruce M, Zhou S-F, Khasraw M, Ward A, Wang L, Wei MQ, et al. EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model. Theranostics. 2015;5(12):1456-72.